BridgeMD
Compares treatment options for Infertility (IVF Patients)
Official title Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
ClinicalTrials.gov ID: NCT06746129
What this study is testing
- What it's testing
- Infertility affects more than 6 million women the United States and is a major life event that results in a wide range of socio-cultural, emotional, physical and financial problems. The most successful treatment for infertility, in-vitro fertilization (IVF), fertilizes a woman's eggs with her partner's sperm in a culture dish and transfers the resulting embryos into the uterus.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 44, women only
You may be able to join if
- autologous IVF cycle
- ≤5 zygotes on day 1 of development
- Fresh embryo transfer
You likely can't join if
- Planned preimplantation genetic testing (PGT) of all embryos
- More than 2 previous IVF cycles
- History of recurrent pregnancy loss (≥3)
- Body mass index \>40
- Presence of uterine factor infertility
- Planned gestational carrier
See the full eligibility criteria
- autologous IVF cycle
- ≤5 zygotes on day 1 of development
- Fresh embryo transfer
- Planned preimplantation genetic testing (PGT) of all embryos
- More than 2 previous IVF cycles
- History of recurrent pregnancy loss (≥3)
- Body mass index \>40
- Presence of uterine factor infertility
- Planned gestational carrier
- Endometrial lining \<6mm measured on the day of trigger
- Lupron-only trigger, elevated progesterone in the fresh cycle (≥1.5ng/ml)
- Delayed fertilization (\>18 hours)
- Rescue intracytoplasmic sperm injection (following failed regular fertilization)
- Use of non-ejaculated sperm (testicular sperm extraction)
- Embryo transfer number outside American Society of Reproductive Medicine (ASRM) guidelines
- Cycle is converted to a cycle in which all embryos are frozen
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 44 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.